Keybank National Association Gsk PLC Transaction History

Keybank National Association

$25.5 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$42.05 - $47.77 $29,855 - $33,916	710 Added 1.81%	39,929 $1.74 Million
Q1 2022 Apr 28, 2022	SELL	$40.23 - $47.74 $45,419 - $53,898	-1,129 Reduced 2.8%	39,219 $1.71 Million
Q4 2021 Feb 07, 2022	SELL	$38.88 - $45.31 $100,815 - $117,488	-2,593 Reduced 6.04%	40,348 $1.78 Million
Q3 2021 Nov 08, 2021	SELL	$38.79 - $43.16 $220,831 - $245,709	-5,693 Reduced 11.71%	42,941 $1.64 Million
Q2 2021 Aug 12, 2021	BUY	$36.52 - $41.46 $34,913 - $39,635	956 Added 2.01%	48,634 $1.94 Million
Q1 2021 May 07, 2021	SELL	$34.27 - $40.01 $52,021 - $60,735	-1,518 Reduced 3.09%	47,678 $1.7 Million
Q4 2020 Feb 09, 2021	SELL	$34.07 - $39.94 $148,272 - $173,818	-4,352 Reduced 8.13%	49,196 $1.81 Million
Q3 2020 Oct 29, 2020	BUY	$38.11 - $42.99 $10,137 - $11,435	266 Added 0.5%	53,548 $2.02 Million
Q2 2020 Aug 10, 2020	SELL	$37.87 - $43.58 $72,861 - $83,847	-1,924 Reduced 3.49%	53,282 $2.17 Million
Q1 2020 May 13, 2020	SELL	$32.47 - $48.83 $165,564 - $248,984	-5,099 Reduced 8.46%	55,206 $2.09 Million
Q4 2019 Feb 05, 2020	SELL	$42.0 - $48.25 $25,830 - $29,673	-615 Reduced 1.01%	60,305 $2.83 Million
Q3 2019 Nov 04, 2019	SELL	$40.46 - $43.52 $206,710 - $222,343	-5,109 Reduced 7.74%	60,920 $2.6 Million
Q2 2019 Aug 01, 2019	SELL	$39.4 - $42.7 $37,745 - $40,906	-958 Reduced 1.43%	66,029 $2.64 Million
Q1 2019 May 08, 2019	SELL	$38.57 - $42.69 $121,264 - $134,217	-3,144 Reduced 4.48%	66,987 $2.8 Million
Q4 2018 Jan 30, 2019	SELL	$37.8 - $42.69 $195,690 - $221,006	-5,177 Reduced 6.87%	70,131 $2.68 Million
Q3 2018 Nov 08, 2018	SELL	$39.75 - $42.69 $67,296 - $72,274	-1,693 Reduced 2.2%	75,308 $3.03 Million
Q2 2018 Aug 08, 2018	SELL	$39.61 - $42.76 $152,934 - $165,096	-3,861 Reduced 4.77%	77,001 $3.1 Million
Q1 2018 May 15, 2018	SELL	$36.18 - $40.15 $115,052 - $127,677	-3,180 Reduced 3.78%	80,862 $3.16 Million
Q4 2017 Feb 08, 2018	SELL	$35.34 - $41.9 $293,463 - $347,937	-8,304 Reduced 8.99%	84,042 $2.98 Million
Q3 2017 Nov 02, 2017	SELL	$39.44 - $41.55 $166,673 - $175,590	-4,226 Reduced 4.38%	92,346 $3.75 Million
Q2 2017 May 14, 2018	SELL	N/A	-3,843 Reduced 3.83%	96,572 $4.16 Million
Q1 2017 May 14, 2018	SELL	N/A	-2,120 Reduced 2.07%	100,415 $4.23 Million
Q4 2016 May 14, 2018	BUY	N/A	102,535	102,535 $3.95 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Account